Identification of low-risk febrile neutroene cancer patients essay
Definitions. A recent article has highlighted the lack of an agreed definition of fever, and the variability between units caring for children with cancer. Phillips B. et al. 2007. The Infectious Diseases Society Guidelines for the Use of Antimicrobials in Neutropenic Patients with Cancer defines fever as a single oral treatment. Both the MASCC and CISNE scores have reasonable discriminatory value in predicting patients with low-risk febrile neutropenia and should be used in combination with clinical judgment for the identification of patients suitable for the outpatient treatment of neutropenic fever . Purpose Patients with febrile neutropenia are heterogeneous. In severe neutropenia, the absolute neutrophil ANC count is lower per microliter. Febrile neutropenia is the most common serious and common complication of cancer therapy. This activity reviews treatment and highlights the tools an interprofessional team needs to appropriately evaluate patients with febrile neutropenia; Introduction. Febrile neutropenia FN is one of the most common adverse events associated with the administration of myelosuppressive chemotherapy for the treatment of cancer. There are several definitions of FN according to the European Society for Medical Oncology ESMO. FN is defined as: 'An oral temperature of gt 38. or two,